FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jörn Bullerdiek

Research Profile

Procedures

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Dogs

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Dominique Nadine Markowski; Rolf Nimzyk; Göran Stenman; Sonja Huhle; Thomas Löning; Jörn Bullerdiek
MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors.
Meenakshi Prabhune; Gazanfer Belge; Jörn Bullerdiek; Andreas Dotzauer; Manfred Radmacher
Comparison of mechanical properties of normal and malignant thyroid cells.
Dominique Nadine Markowski; S Bartnitzke; Norbert Drieschner; Burkhard Maria Helmke; Thomas Löning; Jörn Bullerdiek
MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jörn Bullerdiek (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Dominique Nadine Markowski; Rolf Nimzyk; Göran Stenman; Sonja Huhle; Thomas Löning; Jörn Bullerdiek
MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors.
Genes, chromosomes & cancer 2013;52(3):297-304.
2012: Meenakshi Prabhune; Gazanfer Belge; Jörn Bullerdiek; Andreas Dotzauer; Manfred Radmacher
Comparison of mechanical properties of normal and malignant thyroid cells.
Micron (Oxford, England : 1993) 2012;43(12):1267-72.
2012: Dominique Nadine Markowski; S Bartnitzke; Norbert Drieschner; Burkhard Maria Helmke; Thomas Löning; Jörn Bullerdiek
MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.
International journal of cancer. Journal international du cancer 2012;131(7):1528-36.
2012: Inga Flor; Jörn Bullerdiek
The dark side of a success story: microRNAs of the C19MC cluster in human tumours.
The Journal of pathology 2012;227(3):270-4.
2012: Inga Flor; Catharina Freter; Burkhard Maria Helmke; Marc Langenbuch; Armin Neumann; Volkhard Rippe; Jörn Bullerdiek
Abundant expression and hemimethylation of C19MC in cell cultures from placenta-derived stromal cells.
Biochemical and biophysical research communications 2012;422(3):411-6.
2012: Burkhard Maria Helmke; Dominique Nadine Markowski; Anke Meyer; Jörn Bullerdiek
The expression of HMGA2 varies strongly among colon carcinomas.
Anticancer research 2012;32(5):1589-93.
2012: Gazanfer Belge; Klaus-Peter Dieckmann; Meike Spiekermann; Thomas Balks; Jörn Bullerdiek
Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers for testicular germ cell tumors?
European urology 2012;61(5):1068-9.
2012: Markus Klemke; Gazanfer Belge; Käte Burchardt; Norbert Drieschner; Klaus Junker; Jörn Bullerdiek
Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR.
Genes, chromosomes & cancer 2012;51(4):402-8.
2012: Wolfgang Sendt; Norbert Drieschner; Inga Flor; Volkhard Rippe; Jörn Bullerdiek
Monosomy and ring chromosome 13 in a thyroid nodular goiter-do we underestimate its relevance in benign thyroid lesions?
Cancer genetics 2012;205(3):128-30.
2012: Volkhard Rippe; B Rommel; Johannes Wolfram Debler; Norbert Drieschner; Inga Flor; Klaus Junker; Daniel Krause; Jörn Bullerdiek
Activation of the two microRNA clusters C19MC and miR-371-3 does not play prominent role in thyroid cancer.
Molecular cytogenetics 2012;5(1):40.
2012: Katharina A Sterenczak; Patrick Wefstaedt; Saskia Willenbrock; Jörn Bullerdiek; Martina Dorsch; Silke Glage; Hans Hedrich; Martin Meier; Matthias Meyer; Hugo Murua Escobar; Ingo Nolte
Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer.
BMC cancer 2012;12():284.
2012: Jörn Bullerdiek; Inga Flor
Exosome-delivered microRNAs of "chromosome 19 microRNA cluster" as immunomodulators in pregnancy and tumorigenesis.
Molecular cytogenetics 2012;5(1):27.
2012: Dominique N Markowski; Arlo Radtke; Werner Wosniok; Sabine Bartnitzke; Gazanfer Belge; Iris Czybulka-Jachertz; Ulrich Deichert; Jennifer Froeb; Burkhard M Helmke; Jörn Bullerdiek
Fibroid explants reveal a higher sensitivity against MDM2-inhibitor nutlin-3 than matching myometrium.
BMC women's health 2012;12():2.
2011: Dominique Nadine Markowski; Frauke Meyer; Rolf Nimzyk; Ingo Nolte; Inga von Ahsen; Burkhard Maria Helmke; Jörn Bullerdiek
BMP4 increases expression of HMGA2 in mesenchymal stem cells.
Cytokine 2011;56(3):811-6.
2011: Gazanfer Belge; Igor Buchwalow; Jörn Bullerdiek; Andreas Dendorfer; Anke Meyer; Vishal Nigam; Rolf Nimzyk; Arlo Radtke; Doreen Richardt; Hans H Sievers; Isabel Stegen; Markus Tiemann; Salah A Mohamed
Upregulation of the high mobility group AT-hook 2 gene in acute aortic dissection is potentially associated with endothelial-mesenchymal transition.
Histology and histopathology 2011;26(8):1029-37.
2011: Norbert Drieschner; Klaus Junker; Yvonne Kiefer; Anne Laabs; Rolf Nimzyk; Volkhard Rippe; B Rommel; Gazanfer Belge; Jörn Bullerdiek; Lea Dittberner; Wolfgang Sendt
Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics.
Cancer genetics 2011;204(7):366-74.
2011: Dominique Nadine Markowski; Nina Winter; Frauke Meyer; Inga von Ahsen; Heiner Wenk; Ingo Nolte; Jörn Bullerdiek
p14Arf acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis.
Genes, chromosomes & cancer 2011;50(7):489-98.
2011: Markus Klemke; Anne Laabs; Volkhard Rippe; Gazanfer Belge; Jörn Bullerdiek; Norbert Drieschner; Wolfgang Sendt
On the prevalence of the PAX8-PPARG fusion resulting from the chromosomal translocation t(2;3)(q13;p25) in adenomas of the thyroid.
Cancer genetics 2011;204(6):334-9.
2011: Katharina A Sterenczak; Sven Kleinschmidt; Patrick Wefstaedt; Nina Eberle; Marion Hewicker-Trautwein; Jörn Bullerdiek; Ingo Nolte; Hugo Murua Escobar
Quantitative PCR and immunohistochemical analyses of HMGB1 and RAGE expression in canine disseminated histiocytic sarcoma (malignant histiocytosis).
Anticancer research 2011;31(5):1541-8.
2011: Dominique Nadine Markowski; Burkhard Maria Helmke; Gazanfer Belge; Rolf Nimzyk; Sabine Bartnitzke; Ulrich Deichert; Jörn Bullerdiek
HMGA2 and p14Arf: major roles in cellular senescence of fibroids and therapeutic implications.
Anticancer research 2011;31(3):753-61.
2011: Burkhard Helmke; Dominique Nadine Markowski; Marietta Henrike Müller; Anette Sommer; Jörg Müller; Carsten Möller; Jörn Bullerdiek
HMGA proteins regulate the expression of FGF2 in uterine fibroids.
Molecular human reproduction 2011;17(2):135-42.
2011: Lars Kloth; Siegfried Loeschke; Salah A Mohamed; Rolf Nimzyk; Volkhard Rippe; Werner Wosniok; Gazanfer Belge; Käte Burchardt; Norbert Drieschner; Xin Fu; Jörn Bullerdiek
Decrease in thyroid adenoma associated (THADA) expression is a marker of dedifferentiation of thyroid tissue.
BMC clinical pathology 2011;11():13.
2011: Nicola Reimann-Berg; S Willenbrock; Nina Eberle; Y Kiefer; Reinhard Mischke; Hugo Murua Escobar; Ingo Nolte; Jörn Bullerdiek
Cytogenetic analysis of CpG-oligonucleotide DSP30 plus Interleukin-2-Stimulated canine B-Cell lymphoma cells reveals the loss of one X Chromosome as the sole abnormality.
Cytogenetic and genome research 2011;135(1):79-82.
2011: Nina Winter; Rolf Nimzyk; Carolin Bösche; Anke Meyer; Jörn Bullerdiek
Chromatin immunoprecipitation to analyze DNA binding sites of HMGA2.
PloS one 2011;6(4):e18837.
2011: Nicola Reimann-Berg; S Willenbrock; Hugo Murua Escobar; Nina Eberle; Ingo Gerhauser; Reinhard Mischke; Jörn Bullerdiek; Ingo Nolte
Two new cases of polysomy 13 in canine prostate cancer.
Cytogenetic and genome research 2011;132(1-2):16-21.
2010: Katharina A Sterenczak; Alexa E Joetzke; Saskia Willenbrock; Nina Eberle; Sandra Lange; Christian Junghanss; Ingo Nolte; Jörn Bullerdiek; Daniela Simon; Hugo Murua Escobar
High-mobility group B1 (HMGB1) and receptor for advanced glycation end-products (RAGE) expression in canine lymphoma.
Anticancer research 2010;30(12):5043-8.
2010: Maliheh Hashemi Nezhad; Norbert Drieschner; Sabrina Helms; Anke Meyer; Mahboobeh Tadayyon; Markus Klemke; Gazanfer Belge; S Bartnitzke; Käte Burchardt; Christiane Frantzen; Ernst Heinrich Schmidt; Jörn Bullerdiek
6p21 rearrangements in uterine leiomyomas targeting HMGA1.
Cancer genetics and cytogenetics 2010;203(2):247-52.
2010: Dominique Nadine Markowski; Burkhard Maria Helmke; Jörn Bullerdiek
Cellular senescence in usual type uterine leiomyoma.
Fertility and sterility 2010;94(6):e79; author reply e80.
2010: Dominique Nadine Markowski; S Bartnitzke; Gazanfer Belge; Norbert Drieschner; Burkhard Maria Helmke; Jörn Bullerdiek
Cell culture and senescence in uterine fibroids.
Cancer genetics and cytogenetics 2010;202(1):53-7.
2010: Dominique Nadine Markowski; Inga von Ahsen; Maliheh Hashemi Nezhad; Werner Wosniok; Burkhard Maria Helmke; Jörn Bullerdiek
HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.
Genes, chromosomes & cancer 2010;49(8):661-8.
2010: Yvonne Kiefer; Norbert Drieschner; Henrieke Förster; Markus Tiemann; Christoph Schulte; B Rommel; Jörn Bullerdiek
An unbalanced t(15;18)(q21-q22;p11) as the sole cytogenetic aberration in a patient with B-cell chronic lymphocytic leukemia.
Cancer genetics and cytogenetics 2010;200(1):65-9.
2010: A Meyer; Nina Eberle; Jörn Bullerdiek; Ingo Nolte; D Simon
High-mobility group B1 proteins in canine lymphoma: prognostic value of initial and sequential serum levels in treatment outcome following combination chemotherapy.
Veterinary and comparative oncology 2010;8(2):127-37.
2010: A E Joetzke; K A Sterenczak; Nina Eberle; S Wagner; Jan T Soller; Ingo Nolte; Jörn Bullerdiek; Hugo Murua Escobar; D Simon
Expression of the high mobility group A1 (HMGA1) and A2 (HMGA2) genes in canine lymphoma: analysis of 23 cases and comparison to control cases.
Veterinary and comparative oncology 2010;8(2):87-95.
2010: Markus Klemke; Anke Meyer; Maliheh Hashemi Nezhad; Gazanfer Belge; S Bartnitzke; Jörn Bullerdiek
Loss of let-7 binding sites resulting from truncations of the 3' untranslated region of HMGA2 mRNA in uterine leiomyomas.
Cancer genetics and cytogenetics 2010;196(2):119-23.
2010: Ivaylo Gentschev; Klaas Ehrig; Ulrike Donat; Michael Hess; Stephan Rudolph; Nanhai Chen; Yong A Yu; Qian Zhang; Jörn Bullerdiek; Ingo Nolte; Jochen Stritzker; Aladar A Szalay
Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68.
Journal of oncology 2010;2010():736907.
2010: Volkhard Rippe; Lea Dittberner; Verena N Lorenz; Norbert Drieschner; Rolf Nimzyk; Wolfgang Sendt; Klaus Junker; Gazanfer Belge; Jörn Bullerdiek
The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas.
PloS one 2010;5(3):e9485.
2009: Nina Winter; Anke Meyer; Andreas Richter; Dietz Krisponeit; Jörn Bullerdiek
Elevated levels of HMGB1 in cancerous and inflammatory effusions.
Anticancer research 2009;29(12):5013-7.
2009: André Fehr; G Stenman; Jörn Bullerdiek; Thomas Löning
[Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].
Der Pathologe 2009;30(6):466-71.
2009: André Fehr; Anke Meyer; Klaus Heidorn; Kerstin Röser; Thomas Löning; Jörn Bullerdiek
A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma.
Genes, chromosomes & cancer 2009;48(9):777-85.
2009: Irmgard Verdorfer; André Fehr; Jörn Bullerdiek; Nina Scholz; Andrea Brunner; Jens Krugmann; Martina Hager; Heike Haufe; Gregor Mikuz; Arne W Scholtz
Chromosomal imbalances, 11q21 rearrangement and MECT1-MAML2 fusion transcript in mucoepidermoid carcinomas of the salivary gland.
Oncology reports 2009;22(2):305-11.
2009: Katharina A Sterenczak; Saskia Willenbrock; Matthias Barann; Markus Klemke; Jan T Soller; Nina Eberle; Ingo Nolte; Jörn Bullerdiek; Hugo Murua Escobar
Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms.
Gene 2009;434(1-2):35-42.
2009: Andreas Richter; Gregor Hauschild; Hugo Murua Escobar; Ingo Nolte; Jörn Bullerdiek
Application of high-mobility-group-A proteins increases the proliferative activity of chondrocytes in vitro.
Tissue engineering. Part A 2009;15(3):473-7.
2009: Svea Petersen; Jan T Soller; Siegfried Wagner; Andreas Richter; Jörn Bullerdiek; Ingo Nolte; Stephan Barcikowski; Hugo Murua Escobar
Co-transfection of plasmid DNA and laser-generated gold nanoparticles does not disturb the bioactivity of GFP-HMGB1 fusion protein.
Journal of nanobiotechnology 2009;7():6.
2008: N Winter; A Neumann; Jörn Bullerdiek
Cell-free DNA in amniotic fluid remains to be attached to HMGA2-implications for noninvasive prenatal diagnosis.
Prenatal diagnosis 2008;28(12):1126-30.
2008: Inga von Ahsen; Rolf Nimzyk; Markus Klemke; Jörn Bullerdiek
A microRNA encoded in a highly conserved part of the mammalian HMGA2 gene.
Cancer genetics and cytogenetics 2008;187(1):43-4.
2008: Anke Meyer; Andrea Staratschek-Jox; Anette Springwald; Heiner Wenk; Jurgen Wolf; Claudia Wickenhauser; Jörn Bullerdiek
Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1.
Leukemia & lymphoma 2008;49(6):1184-9.
2008: Nicola Reimann-Berg; Hugo Murua Escobar; Ingo Nolte; Jörn Bullerdiek
Testicular tumor in an XXY dog.
Cancer genetics and cytogenetics 2008;183(2):114-6.
2008: André Fehr; Kerstin Röser; Klaus Heidorn; Cora Hallas; Thomas Löning; Jörn Bullerdiek
A new type of MAML2 fusion in mucoepidermoid carcinoma.
Genes, chromosomes & cancer 2008;47(3):203-6.
2008: André Fehr; Kerstin Röser; Gazanfer Belge; Thomas Löning; Jörn Bullerdiek
A closer look at Warthin tumors and the t(11;19).
Cancer genetics and cytogenetics 2008;180(2):135-9.
2008: Melani A M Fork; Hugo Murua Escobar; Jan T Soller; Katharina A Sterenczak; Saskia Willenbrock; Susanne Winkler; Martina Dorsch; Nicola Reimann-Berg; Hans J Hedrich; Jörn Bullerdiek; Ingo Nolte
Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258.
BMC cancer 2008;8():240.
2008: Jan T Soller; Claudia Beuing; Susanne Winkler; Nicola Reimann-Berg; Norbert Drieschner; Gaudenz Dolf; Claude Schelling; Ingo Nolte; Hugo Murua Escobar; Jörn Bullerdiek
Chromosomal assignment of canine THADA gene to CFA 10q25.
Molecular cytogenetics 2008;1():11.
2008: Gazanfer Belge; Anke Meyer; Markus Klemke; Käte Burchardt; Corinna Stern; Werner Wosniok; Siegfried Loeschke; Jörn Bullerdiek
Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
Genes, chromosomes & cancer 2008;47(1):56-63.
2007: Norbert Drieschner; Svenja Kerschling; Jan T Soller; Volkhard Rippe; Gazanfer Belge; Jörn Bullerdiek; Rolf Nimzyk
A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas.
Gene 2007;403(1-2):110-7.
2007: Britta Meyer; D Krisponeit; C Junghanss; Hugo Murua Escobar; Jörn Bullerdiek
Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count.
Leukemia & lymphoma 2007;48(10):2008-13.
2007: Susanne Winkler; Hugo Murua Escobar; Britta Meyer; Daniela Simon; Nina Eberle; Wolfgang Baumgartner; Siegfried Loeschke; Ingo Nolte; Jörn Bullerdiek
HMGA2 expression in a canine model of prostate cancer.
Cancer genetics and cytogenetics 2007;177(2):98-102.
2007: Britta Meyer; Siegfried Loeschke; Anke Schultze; Thomas Weigel; Martin Sandkamp; Torsten Goldmann; Ekkehard Vollmer; Jörn Bullerdiek
HMGA2 overexpression in non-small cell lung cancer.
Molecular carcinogenesis 2007;46(7):503-11.
2007: Jan T Soller; Hugo Murua Escobar; Saskia Willenbrock; Miriam Janssen; Nina Eberle; Jörn Bullerdiek; Ingo Nolte
Comparison of the human and canine cytokines IL-1(alpha/beta) and TNF-alpha to orthologous other mammalians.
The Journal of heredity 2007;98(5):485-90.
2007: J Jensen; D Simon; Hugo Murua Escobar; H M Escobar; Jan T Soller; Jörn Bullerdiek; Pamela Beelitz; Kurt Pfister; Ingo Nolte
Anaplasma phagocytophilum in dogs in Germany.
Zoonoses and public health 2007;54(2):94-101.
2006: Norbert Drieschner; Gazanfer Belge; Volkhard Rippe; Maren Meiboom; Siegfried Loeschke; Jörn Bullerdiek
Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin.
Thyroid : official journal of the American Thyroid Association 2006;16(11):1091-6.
2006: Jan T Soller; Hugo Murua Escobar; Miriam Janssen; Melani Fork; Jörn Bullerdiek; Ingo Nolte
Cytokine genes single nucleotide polymorphism (SNP) screening analyses in canine malignant histiocytosis.
Anticancer research 2006;26(5A):3417-20.
2006: Inga von Ahsen; Piere Rogalla; Jörn Bullerdiek
Germ line mutations of the HMGA2 gene are rare among the general population.
Anticancer research 2006;26(5A):3289-91.
2006: Susanne Winkler; Nicola Reimann-Berg; Hugo Murua Escobar; Siegfried Loeschke; Nina Eberle; Ruth Höinghaus; Ingo Nolte; Jörn Bullerdiek
Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer.
Cancer genetics and cytogenetics 2006;169(2):154-8.
2006: Hugo Murua Escobar; Jan T Soller; Katharina A Sterenczak; Jan D Sperveslage; Claudia Schlueter; Birgit Burchardt; Nina Eberle; Melanie Fork; Rolf Nimzyk; Susanne Winkler; Ingo Nolte; Jörn Bullerdiek
Cloning and characterization of the canine receptor for advanced glycation end products.
Gene 2006;369():45-52.
2005: Salah Ali Mohamed; Thorsten Hanke; Claudia Schlueter; Jörn Bullerdiek; Hans-Hinrich Sievers
Ubiquitin fusion degradation 1-like gene dysregulation in bicuspid aortic valve.
The Journal of thoracic and cardiovascular surgery 2005;130(6):1531-6.
2005: Susanne Winkler; Hugo Murua Escobar; Nicola Reimann-Berg; Jörn Bullerdiek; Ingo Nolte
Cytogenetic investigations in four canine lymphomas.
Anticancer research 2005;25(6B):3995-8.
2005: Inga von Ahsen; Piere Rogalla; Jörn Bullerdiek
Expression patterns of the LPP-HMGA2 fusion transcript in pulmonary chondroid hamartomas with t(3;12)(q27 approximately 28;q14 approximately 15).
Cancer genetics and cytogenetics 2005;163(1):68-70.
2005: Kerstin Röser; K Thorsten Jäkel; Jörn Bullerdiek; Thomas Löning
[Significance of molecular-cytogenetic findings in mucoepidermoid carcinoma as an example of salivary gland tumors].
Der Pathologe 2005;26(5):359-66.
2005: Carmo Martins; Isabel Fonseca; Lúcia Roque; Teresa Pereira; Catarina Ribeiro; Jörn Bullerdiek; Jorge Soares
PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(8):1048-55.
2005: Sven Hauke; Silke Leopold; Claudia Schlueter; Aljoscha M Flohr; Hugo Murua Escobar; Piere Rogalla; Jörn Bullerdiek
Extensive expression studies revealed a complex alternative splicing pattern of the HMGA2 gene.
Biochimica et biophysica acta 2005;1729(1):24-31.
2005: Claudia Schlueter; Holger Weber; Britta Meyer; Piere Rogalla; Kerstin Röser; Sven Hauke; Jörn Bullerdiek
Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule.
The American journal of pathology 2005;166(4):1259-63.
2005: Alma Kuechler; Monika Ziegler; Cornelia Blank; Birgit Rommel; Jörn Bullerdiek; Jochen Ahrens; Uwe Claussen; Thomas Liehr
A highly complex chromosomal rearrangement between five chromosomes in a healthy female diagnosed in preparation for intracytoplasmatic sperm injection.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2005;53(3):355-7.
2005: Andreas Richter; Hugo Murua Escobar; Kathrin Günther; Jan T Soller; Susanne Winkler; Ingo Nolte; Jörn Bullerdiek
RAS gene hot-spot mutations in canine neoplasias.
The Journal of heredity 2005;96(7):764-5.
2005: Susanne Winkler; Hugo Murua Escobar; Nina Eberle; Nicola Reimann-Berg; Ingo Nolte; Jörn Bullerdiek
Establishment of a cell line derived from a canine prostate carcinoma with a highly rearranged karyotype.
The Journal of heredity 2005;96(7):782-5.
2005: Hugo Murua Escobar; Jan T Soller; Andreas Richter; Britta Meyer; Susanne Winkler; Jörn Bullerdiek; Ingo Nolte
"Best friends" sharing the HMGA1 gene: comparison of the human and canine HMGA1 to orthologous other species.
The Journal of heredity 2005;96(7):777-81.
2005: Claudia Schlueter; Sven Hauke; Siegfried Loeschke; Heiner Hans Wenk; Jörn Bullerdiek
HMGA1 proteins in human atherosclerotic plaques.
Pathology, research and practice 2005;201(2):101-7.
2004: J Meyer; Hugo Murua Escobar; S Bartnitzke; Claude Schelling; Gaudenz Dolf; Ingo Nolte; Jörn Bullerdiek
The FAS-activated serine/threonine kinase gene maps to canine chromosome 16.
Animal genetics 2004;35(6):497.
2004: B Meyer; Hugo Murua Escobar; Susanne Winkler; Gaudenz Dolf; Claude Schelling; Jörn Bullerdiek; Ingo Nolte
Molecular characterization and mapping of the canine cyclin D1 (CCND1) gene.
Animal genetics 2004;35(5):413.
2004: Hugo Murua Escobar; Kathrin Günther; Andreas Richter; Jan T Soller; Susanne Winkler; Ingo Nolte; Jörn Bullerdiek
Absence of ras-gene hot-spot mutations in canine fibrosarcomas and melanomas.
Anticancer research 2004;24(5A):3027-8.
2004: Andreas Richter; Hugo Murua Escobar; Kathrin Günther; B Meyer; Susanne Winkler; Gaudenz Dolf; Claude Schelling; Ingo Nolte; Jörn Bullerdiek
The canine NRAS gene maps to CFA 17.
Animal genetics 2004;35(4):355-6.
2004: Hugo Murua Escobar; J Meyer; Susanne Winkler; Claude Schelling; Gaudenz Dolf; Ingo Nolte; Jörn Bullerdiek
The protein kinase B, gamma (AKT3) gene maps to canine chromosome 7.
Animal genetics 2004;35(4):354-5.
2004: Susanne Winkler; Hugo Murua Escobar; Kathrin Günther; Andreas Richter; Gaudenz Dolf; Claude Schelling; Jörn Bullerdiek; Ingo Nolte
The canine KRAS2 gene maps to chromosome 22.
Animal genetics 2004;35(4):350-1.
2004: Maren Meiboom; Hugo Murua Escobar; Susanne Winkler; Ingo Nolte; Jörn Bullerdiek
Molecular characterization and mapping of the canine KRAB zinc finger gene ZNF331.
Animal genetics 2004;35(3):262-3.
2004: Hugo Murua Escobar; Jan T Soller; Andreas Richter; Britta Meyer; Susanne Winkler; Aljoscha M Flohr; Ingo Nolte; Jörn Bullerdiek
The canine HMGA1.
Gene 2004;330():93-9.
2004: Britta Meyer; Hugo Murua Escobar; Sven Hauke; Andreas Richter; Susanne Winkler; Piere Rogalla; Aljoscha M Flohr; Jörn Bullerdiek; Ingo Nolte
Expression pattern of the HMGB1 gene in sarcomas of the dog.
Anticancer research 2004;24(2B):707-10.
2004: Torsten Goldmann; Aljoscha M Flohr; Hugo Murua Escobar; Bernhard Gerstmayer; Uwe Janssen; Andreas Bosio; Siegfried Loeschke; Ekkehard Vollmer; Jörn Bullerdiek
The HOPE-technique permits Northern blot and microarray analyses in paraffin-embedded tissues.
Pathology, research and practice 2004;200(7-8):511-5.
2003: Lars Borrmann; Ralf Schwanbeck; Tomasz Heyduk; Birte Seebeck; Piere Rogalla; Jörn Bullerdiek; Jacek R Wisniewski
High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity.
Nucleic acids research 2003;31(23):6841-51.
2003: Aljoscha M Flohr; Thomas Hackenbeck; Claudia Schlueter; Piere Rogalla; Jörn Bullerdiek
DNase I treatment of cDNA first strands prevents RT-PCR amplification of contaminating DNA sequences.
BioTechniques 2003;35(5):920-2, 924, 926.
2003: Ana-Maria Bamberger; Antonis Makrigiannakis; Kerstin Röser; Jessica Radde; Tanja Carstens; Aljoscha M Flohr; Christoph M Bamberger; Jörn Bullerdiek; Thomas Löning
Expression of the high-mobility group protein HMGI(Y) in human trophoblast: potential role in trophoblast invasion of maternal tissue.
Virchows Archiv : an international journal of pathology 2003;443(5):649-54.
2003: Claudia Schlueter; Sven Hauke; Aljoscha M Flohr; Piere Rogalla; Jörn Bullerdiek
Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing?
Biochimica et biophysica acta 2003;1630(1):1-6.
2003: Maren Meiboom; Gazanfer Belge; Silvia Bol; Chiraz El-Aouni; Eric F P M Schoenmakers; Jörn Bullerdiek
Does conventional cytogenetics detect the real frequency of 19q13 aberrations in benign thyroid lesions? A survey of 38 cases.
Cancer genetics and cytogenetics 2003;146(1):70-2.
2003: Aljoscha M Flohr; Piere Rogalla; Ulrich Bonk; B Puettmann; Horst Buerger; G Gohla; Jens Packeisen; Werner Wosniok; Siegfried Loeschke; Jörn Bullerdiek
High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade.
Histology and histopathology 2003;18(4):999-1004.
2003: Volkhard Rippe; Norbert Drieschner; Maren Meiboom; Hugo Murua Escobar; Ulrich Bonk; Gazanfer Belge; Jörn Bullerdiek
Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas.
Oncogene 2003;22(38):6111-4.
2003: Karen L Gross; David M Neskey; Nitasha Manchanda; Stanislawa Weremowicz; Michael S Kleinman; Romana A Nowak; Azra H Ligon; Piere Rogalla; Klaus Drechsler; Jörn Bullerdiek; Cynthia C Morton
HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies.
Genes, chromosomes & cancer 2003;38(1):68-79.
2003: Lars Borrmann; B Seebeck; Piere Rogalla; Jörn Bullerdiek
Human HMGA2 promoter is coregulated by a polymorphic dinucleotide (TC)-repeat.
Oncogene 2003;22(5):756-60.
2003: K Becker; Hugo Murua Escobar; Andreas Richter; B Meyer; Ingo Nolte; Jörn Bullerdiek
The canine HMGA1 gene maps to CFA 23.
Animal genetics 2003;34(1):68-9.
2003: Klaus Kayser; Delia Dünnwald; Bernd Kazmierczak; Jörn Bullerdiek; Herbert Kaltner; Yehiel Zick; Sabine André; Hans-Joachim Gabius
Chromosomal aberrations, profiles of expression of growth-related markers including galectins and environmental hazards in relation to the incidence of chondroid pulmonary hamartomas.
Pathology, research and practice 2003;199(9):589-98.
2003: Maren Meiboom; Hugo Murua Escobar; F Pentimalli; Alfredo Fusco; Gazanfer Belge; Jörn Bullerdiek
A 3.4-kbp transcript of ZNF331 is solely expressed in follicular thyroid adenomas.
Cytogenetic and genome research 2003;101(2):113-7.
2003: Hugo Murua Escobar; Britta Meyer; Andreas Richter; K Becker; Aljoscha M Flohr; Jörn Bullerdiek; Ingo Nolte
Molecular characterization of the canine HMGB1.
Cytogenetic and genome research 2003;101(1):33-8.
2002: Martina Vockerodt; Gazanfer Belge; Martin Hafner; Johannes Irsch; Reiner Siebert; Hans Tesch; Volker Diehl; Jürgen Wolf; Jörn Bullerdiek; Andrea Staratschek-Jox
An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591.
British journal of haematology 2002;119(3):640-6.
2002: Inga von Ahsen; Piere Rogalla; Felix Grundmann; Wolf Peter Kunze; Rolf Haupt; Jörn Bullerdiek
Expression of the HMGA2-LPP fusion transcript in only 1 of 61 karyotypically normal pulmonary chondroid hamartomas.
Cancer genetics and cytogenetics 2002;138(2):160-4.
2002: Piere Rogalla; Roger Helbig; Norbert Drieschner; Aljoscha M Flohr; Maren Krohn; Jörn Bullerdiek
Molecular-cytogenetic analysis of fragmentation of chromosome 17 in the breast cancer cell line EFM-19.
Anticancer research 2002;22(4):1987-92.
2002: Sven Hauke; Aljoscha M Flohr; Piere Rogalla; Jörn Bullerdiek
Sequencing of intron 3 of HMGA2 uncovers the existence of a novel exon.
Genes, chromosomes & cancer 2002;34(1):17-23.
2002: Piere Rogalla; Inga von Ahsen; Jörn Bullerdiek
Absence of HMGIC-LHFP fusion in pulmonary chondroid hamartomas with aberrations involving chromosomal regions 12q13 through 15 and 13q12 through q14.
Cancer genetics and cytogenetics 2002;133(1):90-3.
2002: Eva Röijer; Anders Nordkvist; Anna-Karin Ström; Walter Ryd; Margareta Behrendt; Jörn Bullerdiek; Joachim Mark; Göran Stenman
Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma.
The American journal of pathology 2002;160(2):433-40.
2001: Aljoscha M Flohr; Piere Rogalla; Maren Meiboom; Lars Borrmann; M Krohn; B Thode-Halle; Jörn Bullerdiek
Variation of HMGB1 expression in breast cancer.
Anticancer research 2001;21(6A):3881-5.
2001: Piere Rogalla; C Blank; Roger Helbig; Werner Wosniok; Jörn Bullerdiek
Significant correlation between the breakpoints of rare clonal aberrations in benign solid tumors and the assignment of HMGIY retropseudogenes.
Cancer genetics and cytogenetics 2001;130(1):51-6.
2001: Inga von Ahsen; Piere Rogalla; Jörn Bullerdiek
Large deletion of part of the HMGIC locus accompanying a t(3;12)(q27 approximately q28;q14 approximately q15) in a lipoma.
Cancer genetics and cytogenetics 2001;129(2):161-4.
2001: Lars Borrmann; S Wilkening; Jörn Bullerdiek
The expression of HMGA genes is regulated by their 3'UTR.
Oncogene 2001;20(33):4537-41.
2001: Silvia Bol; Gazanfer Belge; B Thode; Ulrich Bonk; S Bartnitzke; Jörn Bullerdiek
Cytogenetic tetraclonality in a rare spindle cell variant of an anaplastic carcinoma of the thyroid.
Cancer genetics and cytogenetics 2001;125(2):163-6.
2001: Sven Hauke; Volkhard Rippe; Jörn Bullerdiek
Chromosomal rearrangements leading to abnormal splicing within intron 4 of HMGIC?
Genes, chromosomes & cancer 2001;30(3):302-4.
2001: Andrea Staratschek-Jox; Roman K Thomas; Thomas Zander; Nadia Massoudi; Martin Kornacker; Jörn Bullerdiek; Christa Fonatsch; Volker Diehl; Jürgen Wolf
Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236.
British journal of cancer 2001;84(3):381-7.
2001: A Piekielko; A Drung; Piere Rogalla; Ralf Schwanbeck; Tomasz Heyduk; M Gerharz; Jörn Bullerdiek; J R Wiśniewski
Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation.
The Journal of biological chemistry 2001;276(3):1984-92.
2001: Silvia Bol; Gazanfer Belge; Volkhard Rippe; Jörn Bullerdiek
Molecular cytogenetic investigations define a subgroup of thyroid adenomas with 2p21 breakpoints clustered to a region of less than 450 kb.
Cytogenetics and cell genetics 2001;95(3-4):189-91.
2001: Inga von Ahsen; Piere Rogalla; Jörn Bullerdiek
A novel LPP fusion gene indicates the crucial role of truncated LPP proteins in lipomas and pulmonary chondroid hamartomas.
Cytogenetics and cell genetics 2001;95(3-4):153-6.
2001: C Blank; Eric F P M Schoenmakers; Piere Rogalla; Erik H L P G Huys; A A van Rijk; Norbert Drieschner; Jörn Bullerdiek
Intragenic breakpoint within RAD51L1 in a t(6;14)(p21.3;q24) of a pulmonary chondroid hamartoma.
Cytogenetics and cell genetics 2001;95(1-2):17-9.
2001: Hugo Murua Escobar; K Becker; Jörn Bullerdiek; I Nolte
The canine ERBB2 gene maps to a chromosome region frequently affected by aberrations in tumors of the dog (Canis familiaris).
Cytogenetics and cell genetics 2001;94(3-4):194-5.
2001: Gazanfer Belge; Volkhard Rippe; Maren Meiboom; Norbert Drieschner; E Garcia; Jörn Bullerdiek
Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations.
Cytogenetics and cell genetics 2001;93(1-2):48-51.
2001: Lars Borrmann; I Kim; D Schultheiss; Piere Rogalla; Jörn Bullerdiek
Regulation of the expression of HMG1, a co-activator of the estrogen receptor.
Anticancer research 2001;21(1A):301-5.
2000: Piere Rogalla; Inga von Ahsen; B Kazmierczak; Jörn Bullerdiek
An identical HMGIC-LPP fusion transcript is consistently expressed in pulmonary chondroid hamartomas with t(3;12)(q27-28;q14-15).
Genes, chromosomes & cancer 2000;29(4):363-6.
2000: Ralf Schwanbeck; M Gerharz; A Drung; Piere Rogalla; A Piekielko; C Blank; Jörn Bullerdiek; J R Wiśniewski
Point mutations within AT-hook domains of the HMGI homologue HMGIYL1 affect binding to gene promoter but not to four-way junction DNA.
Biochemistry 2000;39(47):14419-25.
2000: C Blank; Piere Rogalla; KH Tran; Jörn Bullerdiek
A novel high mobility group protein gene is a candidate for Xp22 abnormalities in uterine leiomyomas and other benign tumors.
Cancer genetics and cytogenetics 2000;121(2):172-80.
2000: Stephanie Spranger; B Rommel; Anna Jauch; R Bodammer; B Mehl; Jörn Bullerdiek
Interstitial deletion of 5q33.3q35.1 in a girl with mild mental retardation.
American journal of medical genetics 2000;93(2):107-9.
2000: B Santulli; B Kazmierczak; R Napolitano; Irene Caliendo; Gennaro Chiappetta; Volkhard Rippe; Jörn Bullerdiek; Alfredo Fusco
A 12q13 translocation involving the HMGI-C gene in richter transformation of a chronic lymphocytic leukemia.
Cancer genetics and cytogenetics 2000;119(1):70-3.
2000: Y Hennig; S Löschke; D Katenkamp; S Bartnitzke; Jörn Bullerdiek
A malignant triton tumor with an unbalanced translocation (1;13)(q10;q10) and an isochromosome (8)(q10) as the sole karyotypic abnormalities.
Cancer genetics and cytogenetics 2000;118(1):80-2.
2000: B Kazmierczak; Paola Dal Cin; Piere Rogalla; Herman Van Den Berghe; Jörn Bullerdiek
Regional fine mapping of HMG17 to chromosomal band 1p35.
Cancer genetics and cytogenetics 2000;116(2):164-5.
2000: Piere Rogalla; B Kazmierczak; Aljoscha M Flohr; Sven Hauke; Jörn Bullerdiek
Back to the roots of a new exon--the molecular archaeology of a SP100 splice variant.
Genomics 2000;63(1):117-22.
2000: Andrea Staratschek-Jox; S Kotkowski; Gazanfer Belge; T Rüdiger; Jörn Bullerdiek; Volker Diehl; Jürgen Wolf
Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
The American journal of pathology 2000;156(1):209-16.
1999: Y Hennig; U Deichert; Ulrich Bonk; B Thode; S Bartnitzke; Jörn Bullerdiek
Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells.
Molecular human reproduction 1999;5(12):1150-4.
1999: Volkhard Rippe; Gazanfer Belge; Maren Meiboom; B Kazmierczak; Alfredo Fusco; Jörn Bullerdiek
A KRAB zinc finger protein gene is the potential target of 19q13 translocation in benign thyroid tumors.
Genes, chromosomes & cancer 1999;26(3):229-36.
1999: Silvia Bol; Gazanfer Belge; B Thode; S Bartnitzke; Jörn Bullerdiek
Structural abnormalities of chromosome 2 in benign thyroid tumors. Three new cases and review of the literature.
Cancer genetics and cytogenetics 1999;114(1):75-7.
1999: Jörn Bullerdiek; B Rommel
Diagnostic and molecular implications of specific chromosomal translocations in mesenchymal tumors.
Histology and histopathology 1999;14(4):1165-73.
1999: N Hörsting; Peter Wohlsein; Nicola Reimann-Berg; S Bartnitzke; Jörn Bullerdiek; Ingo Nolte
Cytogenetic analysis of three oropharyngeal malignant melanomas in dogs.
Research in veterinary science 1999;67(2):149-51.
1999: B Kazmierczak; K Meyer-Bolte; KH Tran; W Wöckel; I Breightman; J Rosigkeit; S Bartnitzke; Jörn Bullerdiek
A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas.
Genes, chromosomes & cancer 1999;26(2):125-33.
1999: B Kazmierczak; Paola Dal Cin; R Sciot; Herman Van Den Berghe; Jörn Bullerdiek
Inflammatory myofibroblastic tumor with HMGIC rearrangement.
Cancer genetics and cytogenetics 1999;112(2):156-60.
1999: C Rohen; Piere Rogalla; K Meyer-Bolte; S Bartnitzke; R Chilla; Jörn Bullerdiek
Pleomorphic adenomas of the salivary glands: absence of HMGIY rearrangements.
Cancer genetics and cytogenetics 1999;111(2):178-81.
1999: Nicola Reimann-Berg; Ingo Nolte; Ulrich Bonk; S Bartnitzke; Jörn Bullerdiek
Cytogenetic investigation of canine lipomas.
Cancer genetics and cytogenetics 1999;111(2):172-4.
1999: B Kazmierczak; Paola Dal Cin; K Meyer-Bolte; Herman Van Den Berghe; Jörn Bullerdiek
HMG1 is not rearranged by 13q12 aberrations in lipomas.
Genes, chromosomes & cancer 1999;24(3):290-2.
1999: Paola Dal Cin; A Fusco; G Belge; Gennaro Chiappetta; Monica Fedele; Patrick Pauwels; Jörn Bullerdiek; Herman Van Den Berghe
Involvement of the HMGI(Y) gene in a microfollicular adenoma of the thyroid.
Genes, chromosomes & cancer 1999;24(3):286-9.
1999: B Kazmierczak; Lars Borrmann; Jörn Bullerdiek
Assignment of a new gene (LBH).
Genomics 1999;56(1):136-7.
1999: P Polito; Paola Dal Cin; B Kazmierczak; Piere Rogalla; Jörn Bullerdiek; Herman Van Den Berghe
Deletion of HMG17 in uterine leiomyomas with ring chromosome 1.
Cancer genetics and cytogenetics 1999;108(2):107-9.
1999: Nicola Reimann-Berg; S Bartnitzke; Ingo Nolte; Jörn Bullerdiek
Working with canine chromosomes: current recommendations for karyotype description.
The Journal of heredity 1999;90(1):31-4.
1999: Y Hennig; Jörg Caselitz; Corinna Stern; S Bartnitzke; Jörn Bullerdiek
Karyotype evolution in a case of uterine angioleiomyoma.
Cancer genetics and cytogenetics 1999;108(1):79-80.
1998: B Kazmierczak; Paola Dal Cin; S Wanschura; Lars Borrmann; Alfredo Fusco; Herman Van Den Berghe; Jörn Bullerdiek
HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors.
Genes, chromosomes & cancer 1998;23(4):279-85.
1998: A Jox; E Taquia; Martina Vockerodt; Andreas Draube; M Pawlita; Peter Möller; Jörn Bullerdiek; Volker Diehl; Jürgen Wolf
Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Cancer research 1998;58(21):4930-9.
1998: Piere Rogalla; K Drechsler; W Schröder-Babo; K Eberhardt; Jörn Bullerdiek
HMGIC expression patterns in non-small lung cancer and surrounding tissue.
Anticancer research 1998;18(5A):3327-30.
1998: N Hörsting; A von Reiswitz; Peter Wohlsein; Jörn Bullerdiek; Nicola Reimann-Berg; Ingo Nolte
[Oropharyngeal tumors of dogs--a clinical study of 79 cases].
Berliner und Münchener tierärztliche Wochenschrift 1998;111(7-8):242-7.
1998: Paola Dal Cin; Dirk Timmerman; Ivo Van den Berghe; S Wanschura; B Kazmierczak; Ignace Vergote; Jan Deprest; P Neven; Philippe Moerman; Jörn Bullerdiek; Herman Van Den Berghe
Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen.
Cancer research 1998;58(11):2278-81.
1998: B Kazmierczak; Jörn Bullerdiek; K H Pham; S Bartnitzke; H Wiesner
Intron 3 of HMGIC is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years.
Cancer genetics and cytogenetics 1998;103(2):175-7.
1998: B Staats; Ulrich Bonk; G Gohla; S Bartnitzke; Jörn Bullerdiek
Two cases of fibrocystic breast disease with polysomy 18 as the sole clonal cytogenetic abnormality.
Cancer genetics and cytogenetics 1998;103(2):91-4.
1998: Piere Rogalla; B Kazmierczak; K Meyer-Bolte; KH Tran; Jörn Bullerdiek
The t(3;12)(q27;q14-q15) with underlying HMGIC-LPP fusion is not determining an adipocytic phenotype.
Genes, chromosomes & cancer 1998;22(2):100-4.
1998: Paola Dal Cin; S Wanschura; B Kazmierczak; Giovanni Tallini; Angelo P Dei Tos; Jörn Bullerdiek; Ivo Van den Berghe; Philippe Moerman; Herman Van Den Berghe
Amplification and expression of the HMGIC gene in a benign endometrial polyp.
Genes, chromosomes & cancer 1998;22(2):95-9.
1998: L Roque; A Clode; Gazanfer Belge; A Pinto; S Bartnitzke; J R Santos; B Thode; Jörn Bullerdiek; S Castedo; J Soares
Follicular thyroid carcinoma: chromosome analysis of 19 cases.
Genes, chromosomes & cancer 1998;21(3):250-5.
1998: B Kazmierczak; Paola Dal Cin; S Wanschura; S Bartnitzke; Herman Van Den Berghe; Jörn Bullerdiek
Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors.
The American journal of pathology 1998;152(2):431-5.
1998: Nicola Reimann-Berg; S Bartnitzke; Jörn Bullerdiek; R Mischke; Ingo Nolte
Trisomy 1 in a canine acute leukemia indicating the pathogenetic importance of polysomy 1 in leukemias of the dog.
Cancer genetics and cytogenetics 1998;101(1):49-52.
1998: Gazanfer Belge; L Roque; J Soares; S Bruckmann; B Thode; E Fonseca; A Clode; S Bartnitzke; S Castedo; Jörn Bullerdiek
Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology.
Cancer genetics and cytogenetics 1998;101(1):42-8.
1998: Piere Rogalla; Z Borda; K Meyer-Bolte; KH Tran; Sven Hauke; Rolf Nimzyk; Jörn Bullerdiek
Mapping and molecular characterization of five HMG1-related DNA sequences.
Cytogenetics and cell genetics 1998;83(1-2):124-9.
1997: Gazanfer Belge; E Garcia; Volkhard Rippe; Alfredo Fusco; S Bartnitzke; Jörn Bullerdiek
Breakpoints of 19q13 translocations of benign thyroid tumors map within a 400 kilobase region.
Genes, chromosomes & cancer 1997;20(2):201-3.
1997: Y Hennig; Jörg Caselitz; S Bartnitzke; Jörn Bullerdiek
A third case of a low-grade endometrial stromal sarcoma with a t(7;17)(p14 approximately 21;q11.2 approximately 21).
Cancer genetics and cytogenetics 1997;98(1):84-6.
1997: Paola Dal Cin; S Wanschura; Marie-Rose Christiaens; Ivo Van den Berghe; Philippe Moerman; P Polito; B Kazmierczak; Jörn Bullerdiek; Herman Van Den Berghe
Hamartoma of the breast with involvement of 6p21 and rearrangement of HMGIY.
Genes, chromosomes & cancer 1997;20(1):90-2.
1997: B Rommel; Piere Rogalla; A Jox; C V Kalle; B Kazmierczak; J Wolf; Jörn Bullerdiek
HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells.
Leukemia & lymphoma 1997;26(5-6):603-7.
1997: Y Hennig; Piere Rogalla; S Wanschura; G Frey; U Deichert; S Bartnitzke; Jörn Bullerdiek
HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality.
Cancer genetics and cytogenetics 1997;96(2):129-33.
1997: Ingo Nolte; Nicola Reimann-Berg; Jörn Bullerdiek; S Bartnitzke; R Mischke; M Nolte
[Importance of cytogenetic investigations in canine leukemias].
Tierärztliche Praxis 1997;25(4):393-7.
1997: Piere Rogalla; K Drechsler; B Kazmierczak; Volkhard Rippe; Ulrich Bonk; Jörn Bullerdiek
Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade.
Molecular carcinogenesis 1997;19(3):153-6.
1997: S Wanschura; Paola Dal Cin; B Kazmierczak; S Bartnitzke; Herman Van Den Berghe; Jörn Bullerdiek
Hidden paracentric inversions of chromosome arm 12q affecting the HMGIC gene.
Genes, chromosomes & cancer 1997;18(4):322-3.
1997: Gazanfer Belge; Jörg Caselitz; Ulrich Bonk; S Bartnitzke; Jörn Bullerdiek
[Genetic studies of differential fatty tissue tumor diagnosis].
Der Pathologe 1997;18(2):160-6.
1997: Gazanfer Belge; L Roque; B Thode; E Fonseca; J Soares; A Clode; S Bartnitzke; S Castedo; Jörn Bullerdiek
[Cytogenetic changes in benign thyroid gland hyperplasias and adenomas correlated with histology].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1997;81():151-6.
1997: A Jox; C Rohen; Gazanfer Belge; S Bartnitzke; M Pawlita; Volker Diehl; Jörn Bullerdiek; Jürgen Wolf
Integration of Epstein-Barr virus in Burkitt's lymphoma cells leads to a region of enhanced chromosome instability.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():131-5.
1996: B Kazmierczak; Y Pohnke; Jörn Bullerdiek
Fusion transcripts between the HMGIC gene and RTVL-H-related sequences in mesenchymal tumors without cytogenetic aberrations.
Genomics 1996;38(2):223-6.
1996: B Kazmierczak; S Bol; S Wanschura; S Bartnitzke; Jörn Bullerdiek
PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line.
Genes, chromosomes & cancer 1996;17(3):191-3.
1996: Eva Röijer; Koen Kas; I Klawitz; Jörn Bullerdiek; W Van de Ven; Göran Stenman
Identification of a yeast artificial chromosome spanning the 8q12 translocation breakpoint in pleomorphic adenomas with t(3;8)(p21;q12).
Genes, chromosomes & cancer 1996;17(3):166-71.
1996: Piere Rogalla; C Rohen; Ulrich Bonk; Jörn Bullerdiek
Telomeric repeat fragment lengths are not correlated to histological grading in 85 breast cancers.
Cancer letters 1996;106(2):155-61.
1996: B Kazmierczak; S Wanschura; B Rommel; S Bartnitzke; Jörn Bullerdiek
Ten pulmonary chondroid hamartomas with chromosome 6p21 breakpoints within the HMG-I(Y) gene or its immediate surroundings.
Journal of the National Cancer Institute 1996;88(17):1234-6.
1996: Nicola Reimann-Berg; Ingo Nolte; Ulrich Bonk; M Werner; Jörn Bullerdiek; S Bartnitzke
Trisomy 18 in a canine thyroid adenoma.
Cancer genetics and cytogenetics 1996;90(2):154-6.
1996: Piere Rogalla; K Drechsler; G Frey; Y Hennig; B Helmke; Ulrich Bonk; Jörn Bullerdiek
HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors.
The American journal of pathology 1996;149(3):775-9.
1996: S Bol; S Wanschura; B Thode; U Deichert; Wim J M Van De Ven; S Bartnitzke; Jörn Bullerdiek
An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12.
Cancer genetics and cytogenetics 1996;90(1):88-90.
1996: Gazanfer Belge; S Bruckmann; B Thode; S Bartnitzke; Jörn Bullerdiek
Deletions of the short arm of chromosome 2 characterize a new cytogenetic subgroup of benign thyroid tumors.
Genes, chromosomes & cancer 1996;16(2):149-51.
1996: S Wanschura; B Kazmierczak; Y Pohnke; K Meyer-Bolte; S Bartnitzke; Wim J M Van De Ven; Jörn Bullerdiek
Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der(14)t(12;14) as the sole cytogenetic abnormality.
Cancer letters 1996;102(1-2):17-21.
1996: Y Hennig; S Wanschura; U Deichert; S Bartnitzke; Jörn Bullerdiek
Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps.
Molecular human reproduction 1996;2(4):277-83.
1996: C Rohen; B Staats; Ulrich Bonk; S Bartnitzke; Jörn Bullerdiek
Significance of clonal chromosome aberrations in breast fibroadenomas.
Cancer genetics and cytogenetics 1996;87(2):152-5.
1996: Y Hennig; U Deichert; C Stern; A Ghassemi; B Thode; Ulrich Bonk; P Meister; S Bartnitzke; Jörn Bullerdiek
Structural aberrations of chromosome 6 in three uterine smooth muscle tumors.
Cancer genetics and cytogenetics 1996;87(2):148-51.
1996: S Wanschura; Eric F P M Schoenmakers; Christel Huysmans; S Bartnitzke; Wim J M Van De Ven; Jörn Bullerdiek
Mapping of the gene encoding the human hepatoma-derived growth factor (HDGF) with homology to the high-mobility group (HMG)-1 protein to Xq25.
Genomics 1996;32(2):298-300.
1996: E Leuschner; B Staats; G Gohla; S Bartnitzke; Ulrich Bonk; Jörn Bullerdiek
Fluorescence in situ hybridization studies on breast tumor samples for distinguishing between different subsets of breast cancer.
Acta cytologica 1996;40(2):151-7.
1996: B Kazmierczak; J Rosigkeit; S Wanschura; K Meyer-Bolte; Wim J M Van De Ven; K Kayser; B Krieghoff; H Kastendiek; S Bartnitzke; Jörn Bullerdiek
HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors.
Oncogene 1996;12(3):515-21.
1996: B Staats; Ulrich Bonk; S Wanschura; P Hanisch; Eric F P M Schoenmakers; Wim J M Van De Ven; S Bartnitzke; Jörn Bullerdiek
A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family.
Breast cancer research and treatment 1996;38(3):299-303.
1996: Nicola Reimann-Berg; S Bartnitzke; Jörn Bullerdiek; U Schmitz; Piere Rogalla; Ingo Nolte; M Rønne
An extended nomenclature of the canine karyotype.
Cytogenetics and cell genetics 1996;73(1-2):140-4.
1996: S Wanschura; Gazanfer Belge; G Stenman; P Kools; Paola Dal Cin; Eric F P M Schoenmakers; Christel Huysmans; Herman Van Den Berghe; S Bartnitzke; Wim J M Van De Ven; Jörn Bullerdiek
Mapping of the translocation breakpoints of primary pleomorphic adenomas and lipomas within a common region of chromosome 12.
Cancer genetics and cytogenetics 1996;86(1):39-45.
1995: B Kazmierczak; Y Hennig; S Wanschura; Piere Rogalla; S Bartnitzke; W Van de Ven; Jörn Bullerdiek
Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene.
Cancer research 1995;55(24):6038-9.
1995: Eric F P M Schoenmakers; Jan Geurts; P F Kools; R Mols; Christel Huysmans; Jörn Bullerdiek; Herman Van Den Berghe; Wim J M Van De Ven
A 6-Mb yeast artificial chromosome contig and long-range physical map encompassing the region on chromosome 12q15 frequently rearranged in a variety of benign solid tumors.
Genomics 1995;29(3):665-78.
1995: C Rohen; Jörg Caselitz; C Stern; S Wanschura; Eric F P M Schoenmakers; Wim J M Van De Ven; S Bartnitzke; Jörn Bullerdiek
A hamartoma of the breast with an aberration of 12q mapped to the MAR region by fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1995;84(1):82-4.
1995: Jürgen Wolf; A Jox; H Skarbek; T Pukrop; S Bartnitzke; M Pawlita; Volker Diehl; Jörn Bullerdiek
Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
Virology 1995;212(1):179-85.
1995: S Wanschura; B Kazmierczak; Eric F P M Schoenmakers; E Meyen; S Bartnitzke; W Van de Ven; Jörn Bullerdiek; W Schloot
Regional fine mapping of the multiple-aberration region involved in uterine leiomyoma, lipoma, and pleomorphic adenoma of the salivary gland to 12q15.
Genes, chromosomes & cancer 1995;14(1):68-70.
1995: B Kazmierczak; S Wanschura; K Meyer-Bolte; Jörg Caselitz; P Meister; S Bartnitzke; W Van de Ven; Jörn Bullerdiek
Cytogenic and molecular analysis of an aggressive angiomyxoma.
The American journal of pathology 1995;147(3):580-5.
1995: Eric F P M Schoenmakers; S Wanschura; R Mols; Jörn Bullerdiek; Herman Van Den Berghe; Wim J M Van De Ven
Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours.
Nature genetics 1995;10(4):436-44.
1995: B Kazmierczak; S Wanschura; J Rosigkeit; K Meyer-Bolte; K Uschinsky; R Haupt; Eric F P M Schoenmakers; S Bartnitzke; Wim J M Van De Ven; Jörn Bullerdiek
Molecular characterization of 12q14-15 rearrangements in three pulmonary chondroid hamartomas.
Cancer research 1995;55(12):2497-9.
1995: Piere Rogalla; C Rohen; Y Hennig; U Deichert; Ulrich Bonk; Jörn Bullerdiek
Telomere repeat fragment sizes do not limit the growth potential of uterine leiomyomas.
Biochemical and biophysical research communications 1995;211(1):175-82.
1995: B Kazmierczak; C Stern; S Bartnitzke; Jörn Bullerdiek
Non-random jumping translocations as a result of SV40 large T-antigen expression in benign human tumor cells.
Cell biology international 1995;19(4):315-22.
1995: Wim J M Van De Ven; Eric F P M Schoenmakers; S Wanschura; B Kazmierczak; P F Kools; Jan Geurts; S Bartnitzke; Herman Van Den Berghe; Jörn Bullerdiek
Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors.
Genes, chromosomes & cancer 1995;12(4):296-303.
1995: C Rohen; K Meyer-Bolte; Ulrich Bonk; T Ebel; B Staats; E Leuschner; G Gohla; Jörg Caselitz; S Bartnitzke; Jörn Bullerdiek
Trisomy 8 and 18 as frequent clonal and single-cell aberrations in 185 primary breast carcinomas.
Cancer genetics and cytogenetics 1995;80(1):33-9.
1995: P F Kools; S Wanschura; Eric F P M Schoenmakers; Jan Geurts; R Mols; B Kazmierczak; Jörn Bullerdiek; Herman Van Den Berghe; Wim J M Van De Ven
Identification of the chromosome 12 translocation breakpoint region of a pleomorphic salivary gland adenoma with t(1;12)(p22;q15) as the sole cytogenetic abnormality.
Cancer genetics and cytogenetics 1995;79(1):1-7.
1995: Gazanfer Belge; E Garcia; P de Jong; S Bartnitzke; Jörn Bullerdiek
FISH analyses of a newly established thyroid tumor cell line showing a t(1;19)(p35 or p36.1;q13) reveal that the breakpoint lies between 19q13.3-13.4 and 19q13.4.
Cytogenetics and cell genetics 1995;69(3-4):220-2.
1995: S Wanschura; Y Hennig; U Deichert; Eric F P M Schoenmakers; Wim J M Van De Ven; S Bartnitzke; Jörn Bullerdiek
Molecular-cytogenetic refinement of the 12q14-->q15 breakpoint region affected in uterine leiomyomas.
Cytogenetics and cell genetics 1995;71(2):131-5.
1994: Gazanfer Belge; B Thode; S Bartnitzke; Jörn Bullerdiek
Cytogenetic biclonality corresponding to multiphasic differentiation in an atypical thyroid adenoma.
Cancer genetics and cytogenetics 1994;78(1):102-4.
1994: Piere Rogalla; B Kazmierczak; C Rohen; G Trams; S Bartnitzke; Jörn Bullerdiek
Two human breast cancer cell lines showing decreasing telomeric repeat length during early in vitro passaging.
Cancer genetics and cytogenetics 1994;77(1):19-25.
1994: Eric F P M Schoenmakers; R Mols; S Wanschura; P F Kools; Jan Geurts; S Bartnitzke; Jörn Bullerdiek; Herman Van Den Berghe; Wim J M Van De Ven
Identification, molecular cloning, and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas.
Genes, chromosomes & cancer 1994;11(2):106-18.
1994: E Leuschner; K Meyer-Bolte; Jörg Caselitz; S Bartnitzke; Jörn Bullerdiek
Fibroadenoma of the breast showing a translocation (6;14), a ring chromosome and two markers involving parts of chromosome 11.
Cancer genetics and cytogenetics 1994;76(2):145-7.
1994: Gazanfer Belge; B Thode; Volkhard Rippe; S Bartnitzke; Jörn Bullerdiek
A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors.
Human genetics 1994;94(2):198-202.
1994: Eric F P M Schoenmakers; P F Kools; R Mols; B Kazmierczak; S Bartnitzke; Jörn Bullerdiek; Paola Dal Cin; P J De Jong; Herman Van Den Berghe; Wim J M Van De Ven
Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma.
Genomics 1994;20(2):210-22.
1994: Jörn Bullerdiek; Ulrich Bonk; B Staats; E Leuschner; G Gohla; T Ebel; S Bartnitzke
Trisomy 18 as the first chromosome abnormality in a medullary breast cancer.
Cancer genetics and cytogenetics 1994;73(1):75-8.
1994: Sabine Franke; I Klawitz; E Schnakenberg; B Rommel; W Van de Ven; Jörn Bullerdiek; W Schloot
Isolation and mapping of a cosmid clone containing the human NAT2 gene.
Biochemical and biophysical research communications 1994;199(1):52-5.
1994: P F Kools; Anton J M Roebroek; Hilde Van de Velde; Peter Marynen; Jörn Bullerdiek; Wim J M Van De Ven
Regional mapping of the human NSP gene to chromosome region 14q21-->q22 by fluorescence in situ hybridization analysis.
Cytogenetics and cell genetics 1994;66(1):48-50.
1994: Nicola Reimann-Berg; Piere Rogalla; B Kazmierczak; Ulrich Bonk; Ingo Nolte; T Grzonka; S Bartnitzke; Jörn Bullerdiek
Evidence that metacentric and submetacentric chromosomes in canine tumors can result from telomeric fusions.
Cytogenetics and cell genetics 1994;67(2):81-5.
1994: U Kapp; A Düx; E Schell-Frederick; N Banik; Michael Hummel; S Mücke; C Fonatsch; Jörn Bullerdiek; C Gottstein; Andreas Engert
Disseminated growth of Hodgkin's-derived cell lines L540 and L540cy in immune-deficient SCID mice.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 1():121-6.
1993: C Rohen; Ulrich Bonk; B Staats; S Bartnitzke; Jörn Bullerdiek
Two human breast tumors with translocations involving 12q13-15 as the sole cytogenetic abnormality.
Cancer genetics and cytogenetics 1993;69(1):68-71.
1993: Jürgen Wolf; M Pawlita; A Jox; S Kohls; S Bartnitzke; Volker Diehl; Jörn Bullerdiek
Integration of Epstein Barr virus near the breakpoint of a translocation 11;19 in a Burkitt's lymphoma cell line.
Cancer genetics and cytogenetics 1993;67(2):90-4.
1993: H F Schoenmakers; P F Kools; B Kazmierczak; Jörn Bullerdiek; U Claussen; B Horsthemke; Herman Van Den Berghe; Wim J M Van De Ven
Isolation of a somatic cell hybrid retaining the der(16)t(12;16)(q13;p11.2) from a myxoid liposarcoma cell line.
Cytogenetics and cell genetics 1993;62(2-3):159-61.
1993: Jörn Bullerdiek; E Leuschner; E Taquia; Ulrich Bonk; S Bartnitzke
Trisomy 8 as a recurrent clonal abnormality in breast cancer?
Cancer genetics and cytogenetics 1993;65(1):64-7.
1993: Jörn Bullerdiek; G Wobst; K Meyer-Bolte; R Chilla; J Haubrich; B Thode; S Bartnitzke
Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior.
Cancer genetics and cytogenetics 1993;65(1):27-31.
1992: C Stern; U Deichert; B Thode; S Bartnitzke; Jörn Bullerdiek
[Cytogenetic subtyping of 139 uterine leiomyoma].
Geburtshilfe und Frauenheilkunde 1992;52(12):767-72.
1992: S Bartnitzke; H Motzko; C Rosenhagen; Jörn Bullerdiek
Benign mixed tumor of canine mammary gland showing an r(X) and trisomy 5 as the only clonal abnormalities.
Cancer genetics and cytogenetics 1992;62(1):29-31.
1992: B Kazmierczak; B Thode; S Bartnitzke; Jörn Bullerdiek; W Schloot
Pleomorphic adenoma cells vary in their susceptibility to SV40 transformation depending on the initial karyotype.
Genes, chromosomes & cancer 1992;5(1):35-9.
1992: Gazanfer Belge; B Thode; Jörn Bullerdiek; S Bartnitzke
Aberrations of chromosome 19. Do they characterize a subtype of benign thyroid adenomas?
Cancer genetics and cytogenetics 1992;60(1):23-6.
1992: Gazanfer Belge; B Kazmierczak; K Meyer-Bolte; S Bartnitzke; Jörn Bullerdiek
Expression of SV40 T-antigen in lipoma cells with a chromosomal translocation T(3;12) is not sufficient for direct immortalization.
Cell biology international reports 1992;16(4):339-47.
1992: S Bartnitzke; H Motzko; Jörg Caselitz; M Kornberg; Jörn Bullerdiek; W Schloot
A recurrent marker chromosome involving chromosome 1 in two mammary tumors of the dog.
Cytogenetics and cell genetics 1992;60(2):135-7.
1991: Gazanfer Belge; B Thode; Jörn Bullerdiek; S Bartnitzke
Deletion of part of the long arm of chromosome 13 as the only karyotypic aberration in a follicular thyroid adenoma.
Cancer genetics and cytogenetics 1991;56(2):277-80.
1991: C Stern; B Kazmierczak; B Thode; B Rommel; S Bartnitzke; Paola Dal Cin; W van de Ven; Herman Van Den Berghe; Jörn Bullerdiek
Leiomyoma cells with 12q15 aberrations can be transformed in vitro and show a relatively stable karyotype during precrisis period.
Cancer genetics and cytogenetics 1991;54(2):223-8.
1991: B Rommel; E M de Villiers; M Dürst; S Bartnitzke; Jörn Bullerdiek
Failure to detect human papillomavirus sequences at the 3p21 rearrangement site in pleomorphic adenomas.
Cancer genetics and cytogenetics 1991;52(2):187-91.
1990: Jörn Bullerdiek; M Vollrath; C Wittekind; Jörg Caselitz; S Bartnitzke
Mucoepidermoid tumor of the parotid gland showing a translocation (3;8)(p21;q12) and a deletion (5)(q22) as sole chromosome abnormalities.
Cancer genetics and cytogenetics 1990;50(1):161-4.
1990: B Rommel; Jörn Bullerdiek; S Bartnitzke; W Schloot
No rearrangement of c-mos in salivary gland pleomorphic adenomas with 8q12 aberrations.
Cancer genetics and cytogenetics 1990;49(2):165-9.
1990: C Stern; K Meyer; S Bartnitzke; W Schloot; Jörn Bullerdiek
Pleomorphic adenomas with unbalanced chromosomal abnormalities have an increased in vitro lifetime.
Cancer genetics and cytogenetics 1990;46(1):55-63.
1990: Jörn Bullerdiek; K J Hutter; G Brandt; M Weinberg; Gazanfer Belge; S Bartnitzke
Cytogenetic investigations on a cell line derived from a carcinoma arising in a salivary gland pleomorphic adenoma.
Cancer genetics and cytogenetics 1990;44(2):253-62.
1990: S Bartnitzke; D Eberhardt; J Krooss; B Rommel; Jörn Bullerdiek
In situ nick translation of human chromosomes using Alu I: unmasking of recognition sites by proteinase K pretreatment.
Cytobios 1990;62(249):93-9.
1990: B Kazmierczak; S Bartnitzke; M Hartl; Jörn Bullerdiek
In vitro transformation by the SV40 'early region' of cells from a human benign salivary gland tumor with a 12q13----q15 rearrangement.
Cytogenetics and cell genetics 1990;53(1):37-9.
1989: Jörn Bullerdiek; G Takla; S Bartnitzke; G Brandt; R Chilla; J Haubrich
Relationship of cytogenetic subtypes of salivary gland pleomorphic adenomas with patient age and histologic type.
Cancer 1989;64(4):876-80.
1989: S Bartnitzke; M E Herrmann; H Lobeck; W Zuschneid; P Neuhaus; Jörn Bullerdiek
Cytogenetic findings on eight follicular thyroid adenomas including one with a t(10;19).
Cancer genetics and cytogenetics 1989;39(1):65-8.
1988: Jörn Bullerdiek; J Haubrich; K Meyer; S Bartnitzke
Translocation t(11;19)(q21;p13.1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland.
Cancer genetics and cytogenetics 1988;35(1):129-32.
1988: B Rommel; K J Hutter; Jörn Bullerdiek; S Bartnitzke; K Goerttler; W Schloot
Identification of flow-sorted chromosomes by G-banding and in situ hybridization.
Cytometry 1988;9(5):504-7.
1988: Jörn Bullerdiek; R Chilla; J Haubrich; K Meyer; S Bartnitzke
A causal relationship between chromosomal rearrangements and the genesis of salivary gland pleomorphic adenomas.
Archives of oto-rhino-laryngology 1988;245(4):244-9.
1987: Jörn Bullerdiek; G Raabe; C Böschen; S Bartnitzke
Translocation (3;8;8)(p22 or p23;p23;q12) in a case of pleomorphic adenoma: similarity to a primary cytogenetic abnormality detected in an endometrial adenocarcinoma.
Cancer genetics and cytogenetics 1987;27(1):177-80.
1987: Jörn Bullerdiek; G Raabe; S Bartnitzke; C Böschen; W Schloot
Structural rearrangements of chromosome Nr 8 involving 8q12--a primary event in pleomorphic ademona of the parotid gland.
Genetica 1987;72(2):85-92.
1987: Jörn Bullerdiek; C Böschen; S Bartnitzke
Aberrations of chromosome 8 in mixed salivary gland tumors--cytogenetic findings on seven cases.
Cancer genetics and cytogenetics 1987;24(2):205-12.
1987: Jörn Bullerdiek; S Bartnitzke; M Weinberg; R Chilla; J Haubrich; W Schloot
Rearrangements of chromosome region 12q13----q15 in pleomorphic adenomas of the human salivary gland (PSA).
Cytogenetics and cell genetics 1987;45(3-4):187-90.